This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Purdue Research Foundation. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Sijie Wang: Innovator in Chromdomain Inhibitors
Introduction
Sijie Wang is a notable inventor based in Lafayette, IN (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds targeting specific proteins involved in various diseases.
Latest Patents
Sijie Wang holds 2 patents, with his latest inventions focusing on CBX8 chromdomain inhibitors. These peptidomimetic compounds selectively target CBX8 of polycomb chromobox protein homolog proteins. The pharmaceutical compositions of these compounds are designed for the treatment of diseases related to CBX8 pharmacology, including various cancers and leukemia. The methods of using these compounds involve administering therapeutically effective amounts either alone or in combination with other therapeutics.
Career Highlights
Sijie Wang is associated with the Purdue Research Foundation, where he continues to advance his research and innovations. His work has the potential to impact the treatment landscape for serious diseases, showcasing his commitment to improving healthcare outcomes.
Collaborations
He collaborates with talented individuals such as Emily Carla Dykhuizen and Casey J Krusemark, contributing to a dynamic research environment.
Conclusion
Sijie Wang's innovative work in developing CBX8 chromdomain inhibitors highlights his role as a significant contributor to medical research and pharmacology. His patents reflect a dedication to addressing critical health challenges through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile